BB
Belhaven Biopharma Inc.
SEC filingPharmaceuticals · Chapel Hill, NC
Amount raised$32.3Msold at filing
Total offering$32.3M
Investors in the raise222count reported to the SEC
FiledOct 15, 2025first sale Aug 4, 2025
Form D does not name the investors. If a news report names them, they appear here.
Named in the filing
Wes Algon WheelerDirector
David Algon NealExecutive Officer, Director
Derek Algon WinstanlyDirector
Scott David LymanExecutive Officer, Director
Executive officers, directors and promoters as listed on the Form D.